Skip to main content
. 2021 Aug 25;22(17):9168. doi: 10.3390/ijms22179168

Figure 4.

Figure 4

The combination of anti-PD-1 and MTL-CEBPA synergistically reduces CT26 tumor volume. Changes in tumor volume from day 4 to the end of study at day 23. Individual tumor volume for (A) control, (B) MTL-CEBPA, (C) anti-PD-1 and (D) anti-PD-1+MTL-CEBPA treated animals were represented. Mean tumor volume of (E) MTL-CEBPA, (F) anti-PD-1 and (G) anti-PD-1+MTL-CEBPA treated animals were compared against the control group (H) Comparison of mean tumor volume for anti-PD-1 and anti-PD-1+MTL-CEBPA treated group. Statistical significance is indicated as * p < 0.05 and ** p < 0.01.